Get the Stockscreener App
15.83
0.51%
0.08
After Hours:
15.83
Integra Lifesciences Holdings Corp stock is traded at $15.83, with a volume of 429.61K.
It is up +0.51% in the last 24 hours and down -31.53% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$15.75
Open:
$15.59
24h Volume:
429.61K
Relative Volume:
0.67
Market Cap:
$1.29B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
31.66
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
-9.13%
1M Performance:
-31.53%
6M Performance:
-19.89%
1Y Performance:
-50.44%
1-Day Range:
$15.46
$15.96
1-Week Range:
$15.46
$17.46
52-Week Range:
$15.46
$32.66
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
15.83 | 1.29B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Integra LifeSciences to Release First Quarter 2025 Financial Results on May 5, 2025 - Nasdaq
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 - Yahoo Finance
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Truist Adjusts Price Target for Integra LifeSciences (IART) Ahea - GuruFocus
Integra LifeSciences stock hits 52-week low at $16.76 - Investing.com
Integra LifeSciences stock hits 52-week low at $16.76 By Investing.com - Investing.com Canada
Attention Long-Term Shareholders of Axsome Therapeutics, - GlobeNewswire
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Sei Investments Co. - Defense World
Do Options Traders Know Something About Integra (IART) Stock We Don't? - Yahoo Finance
Norges Bank Acquires New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); General Motors Company (NYSE: GM); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and ModivCare, Inc. (NASDAQ: MODV): Act Now as Grabar Law Office Is - GlobeNewswire
Orion Portfolio Solutions LLC Invests $728,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Raymond James Financial Inc. Invests $943,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Argus upgrades Integra to Buy, says well-positioned for a turnaround - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Rating Increased to Buy at Argus - Defense World
Argus raises Integra LifeSciences stock rating to buy, sets $28 target By Investing.com - Investing.com South Africa
Argus raises Integra LifeSciences stock rating to buy, sets $28 target - Investing.com
ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT) - Morningstar
Pediatric Neurology Devices Market Worth, $5.8 Billion by 2031 | - openPR.com
Quantbot Technologies LP Sells 64,470 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
IART INVESTOR REMINDER: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending - ACCESS Newswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: - GlobeNewswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); Outset Medical, Inc. (NASDAQ: OM); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims on Your Behal - Morningstar
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
Notice to Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims On Your Behalf - GlobeNewswire Inc.
Notice to Long-Term Shareholders of Akero Therapeutics, - GlobeNewswire
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is I - TradingView
Victory Capital Management Inc. Sells 9,832 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Grabar Law Investigates Integra LifeSciences (IART) Board for Potential Fiduciary Breach Amid Securities Fraud Allegations – Apnakal market - Apna Kal
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders - Bluefield Daily Telegraph
Notice to Long-Term Integra Lifesciences Holdings - GlobeNewswire
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - TradingView
PNC Financial Services Group Inc. Boosts Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Charles Schwab Investment Management Inc. Increases Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Position Lowered by Bank of New York Mellon Corp - Defense World
3 Reasons IART is Risky and 1 Stock to Buy Instead - Yahoo Finance
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Yahoo Finance
Integra LifeSciences Holdings Corp. to Host Earnings Call - ACCESS Newswire
Amalgamated Bank Has $440,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - SETE News
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up - Yahoo Finance
Decoding Integra Lifesciences Holdings Corp (IART): A Strategic SWOT Insight - GuruFocus
Integra LifeSciences (NASDAQ:IART) Trading Up 5.1%Time to Buy? - MarketBeat
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Investor Network: INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call - ACCESS Newswire
Integra LifeSciences Holdings Corp Releases 2024 Form 10-K Report: A Comprehensive Analysis of Financial Performance, Business Strategy, and Market Challenges - HPBL
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):